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SIGNIFICANCE
Magnetic resonance imaging and sonography are the main 
non-invasive imaging modalities for treatment selection, 
preoperative planning, and evaluation of effectiveness of 
therapy in patients with hidradenitis suppurativa. We re-
port here the application of non-contrast-enhanced 3-Tesla 
magnetic resonance imaging using surface-coil and sono-
graphy for assessment of hidradenitis suppurativa lesions 
based on topographic assessment of skin lesions.
Hidradenitis suppurativa has a substantial negative ef­
fect on quality of life of affected persons. Diagnosis is 
based mainly on clinical examination. However, physi­
cal examination alone might underestimate disease 
severity compared with imaging modalities. We report 
here the application of non­contrast­enhanced 3­Tesla 
magnetic resonance imaging using surface­coil and 
sonography for assessment of hidradenitis suppura­
tiva lesions based on topographic assessment of skin 
lesions. In addition, we review the literature regarding 
the application of ultrasound and magnetic resonance 
imaging in hidradenitis suppurativa.
Key words: 3-Tesla; hidradenitis suppurativa; MRI; sonography; 
surface coil; treatment.
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Hidradenitis suppurativa (HS) is a debilitating, recur-rent, inflammatory dermatological disorder, which 
reduces quality of life, with physical, emotional, and 
psychological consequences (1–3). The clinical mani-
festations of HS range from recurrent inflamed nodules 
and abscesses to draining sinus tracts and scar formation 
(3). The associated pain, drainage, malodour and disfigu-
rement contribute to a remarkable psychosocial impact 
of the disease (3, 4). Diagnosis, clinical evaluation, 
current staging and follow-up of HS are based mainly 
on physical examination of palpable and visible lesions 
(5, 6). How ever, physical examination alone usually 
underestimates disease severity compared with imaging 
modalities (7–9). In addition, surgical treatment of HS 
could benefit from radiological modalities with a higher 
sensitivity, enabling better detection of the extent of HS 
involvement (6–9). Furthermore, improved knowledge 
of HS lesions might aid in the selection of appropriate 
treatments and more precise disease monitoring, which 
could improve clinical outcomes (7–9). This study re-
ports the simultaneous application of sonography and 
non-contrast-enhanced 3-Tesla magnetic resonance 
imaging (MRI) using surface-coil in a patient with 
moderate-to-severe HS (Hurley stage II) to assess the 
topography of the skin lesions. Furthermore, a review 
of the literature is presented regarding the application 
of sonography and MRI in HS. 
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Fig. 1. Right shoulder. (A) Sonography: dermal thickening without fluid collection or fistula formation. (B, C) Magnetic resonance imaging: Both pictures 
show dermal thickening in the coronal and axial sequences, with suspicion of beginning of tiny sinus tract formation on the coronal acquisition. (B) TIRM 
(Turbo-Inversion Recovery-Magnitude) blade coronal right; (C) T2 Blade FS (Fat Suppressed) axial. (D) Clinical image.
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CASE REPORT
A 34-year-old woman presented with a history of recurrent painful 
lesions in the axillae, genital and gluteal area for 4 years. She was 
a smoker and overweight. She had multiple inflamed nodules, co-
medones and scar formation in typical locations for HS (Hidradeni-
tis suppurativa Hurley II) (Figs 1 and 2). In order to better assess 
the superficial cutaneous and subcutaneous structures in the axillae, 
ultrasound was performed using an Acuson Sequoia ultrasound 
system (Siemens Healthineers, Erlangen, Germany) with a Linear 
9 MHz transducer (Figs 1 and 2). This revealed bilateral dermal 
thickening together with some small dermal fluid collection up 
to 10 mm, with no sign of fistula formation on the left axilla. In 
order to complement the results of sonography, a surface-coil 
MRI was performed to assess the topography of the skin lesions. 
Surface-coil MRI enables high-resolution imaging of superficial 
structures, such as the skin, owing to its high signal-to-noise ratio. 
As result, a non-contrast-enhanced MRI was performed using a 3-T 
MRI scanner (Magnetom Prisma; Siemens Healthineers, Erlangen, 
Germany) with a surface shoulder coil. Optimized turbo inversion 
recovery magnitude (TIRM) blade and proton density turbo spin 
echo (PD-TSE) fat suppressed sequences, in axial and coronal 
planes (Table I), were performed. MRI scan of the right/left axilla 
revealed dermal thickening on the coronal and axial sequences, 
with suspicion of the beginning of tiny sinus tract formation on 
the coronal acquisition in the right side and small fluid formation 
on the coronal acquisition in the left side (Figs 1 and 2).
LITERATURE REVIEW
Search strategy
A review was carried out following Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines (10) (Fig. 3). The literature search 
was conducted in PubMed from January 2000 to April 
2020, using the following search terms, their synonyms 
or respective combinations: acne inversa, hidradenitis 
suppurativa, sonography, ultrasound, magnetic resonance 
imaging, and MRI.
Study selection and data collection
A database was made of the initial results, using Microsoft 
Excel. Title, abstracts and publication type were screened 
for inclusion in full-text assessment. Criteria leading to 
study exclusion were: language (other than English), 
comments, and non-human studies. The selected studies 
were then summarized chronologically in a table to show 
Fig. 2. Left shoulder. (A, B) Sonography: in addition 
to routine ultrasound (US) imaging, power Doppler 
and colour Doppler ultrasound modalities can be 
utilized to visualize hidradenitis suppurativa lesions 
and differentiate nearby vasculature. Ultrasound 
shows dermal thickening with some small dermal 
fluid collection up to 10 mm without sign of fistula 
formation. (C, D) Magnetic resonance imaging: both 
pictures show diffuse infiltrating dermal thickening 
in the axial sequences, with small fluid formation 
on the coronal acquisition. No fistula formation. (C) 
TIRM (Turbo-Inversion Recovery-Magnitude) blade 
coronal. (D) PD (Proton Density) TSE (Turbo Spin 
Echo)  FS (Fat Suppressed)  axial. (E)  Clinical image.
441 articles were identified
by searching PubMed
database 
noitacifitnedI
 
39 articles were included in 
the analysis
317 duplicate records were 
removed
74 records were excluded: 
language other than English 
and irrelevant studies
50 records were screened
0 records were excluded: no 
full text available
11 records were excluded: 
Letters to the editor, Reviews, 
Comments
39 articles were assessed
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Fig. 3. Flow of information during the review.
Table I. Parameters for surface coil magnetic resonance imaging 
(MRI)
Parameter TIRM blade PD TSE FS
Repetition time (ms) 3930 3000
Echo time (ms) 45 34
Slice thickness (mm) 3 3
Inversion time (ms) 220 220
Field of view (mm) 200×200 150×150
TIRM: turbo inversion recovery magnitude; PD TSE FS: proton density turbo spin 
echo fat suppressed.
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Table II. Summary of selected studies that showed application of sonography in hidradenitis suppurativa (HS)
Year Study
Patients
n
Selected 
radiological 
method Frequency of probe Comments
1997 Jemec & Gniadecka (12) 15 HS; 13 HC US 20 MHz US shows characteristic differences in the shape of hair follicles 
in HS. A thickened skin may play a pathogenic role in the 
development of HS.
2004 Wortsman, et al. (11) 21 VSD; 13 HC US Linear 15–7 MHz; linear 12–5 
MHz
US allows objective, accurate, non-invasive and easy 
measurements of several parameters of skin morphology.
2007 Wortsman, et al. (17) 7 HS US Linear 15.7- MHz; linear 
17.5- MHz
US shows a number of HS features and can identify the true 
extent of lesions in HS, which may be of use in preoperative 
planning.
2009 Wortsman, et al. (31) 10 HS US Linear 15–7 MHz; linear 12–5 
MHz
Lymph node involvement only occurs with late-stage HS and 
may therefore reflect secondary infection rather than primary 
aetiological involvement.
2010 Kelekis, et al. (28) 19 HS US Linear 7–12 MHz US aids in diagnosis and severity assessment of HS.
2012 Kolodziejczak, et al. (43) 51 HS US Linear 6–12 MHz; Endoprobe 
10–16 MHz
TPUS is an accessible imaging method, which confirms the 
typical localization of changes of HS, and together with AUS it 
allows for the proper differentiation of HS from an anal fistula or 
an abscess.
2013 Wortsman, et al. (16) 25 HS US Linear 7–15 MHz; linear 7–18 
MHz
A 3D US can show the sinus tract formation in HS.
2013 Wortsman, et al. (8) 34 HS US Linear 7–18 MHz US is useful for HS staging.
2015 Wortsman & Wortsman 
(14)
50 HS US Linear 16 MHz; linear 18 MHz Ultrasound can detect retained hair tracts in HS.
2015 Zarchi, et al. (30) 20 HS US Linear 6–18 MHz and linear 
10–22 MHz
Pain and inflammation in HS correspond to morphological 
changes identified by US.
2016 Wortsman, et al. (40) 52 HS US (+ CD) Linear upper range up to 18 
MHz
Fistulous tracts in HS can be categorized using US, which may 
support earlier and precise management.
2016 Wortsman, et al. (19) 12 HS CD Upper range up to 16 and 
18 MHz
US can be a reliable and safe imaging tool to support diagnosis, 
staging and non-invasive monitoring of treatment in children 
with HS.
2017 Wortsman, et al. (34) 43 PC; 41 HS CD Upper range up to 16 and 
18 MHz
Key lesions of PC and HS have similar sonographic 
morphological characteristics, which suggests that a PC may be 
a variant or localized form of HS.
2018 Caposiena Caro, et al. (6) 61 HS CD (+ PD) Linear 10–18 MHz Vascular distribution of HS lesions can be evaluated by PD with 
additional relevant information for earlier and better disease 
management.
2018 Loo, et al. (20) 62 HS US NM US can add diagnostic information to the clinical and 
biochemical characteristics of patients with HS.
2018 Nazzaro, et al. (36) 140 HS US Linear 18–5-MHz Ultrasonography may reveal non-clinically evident HS lesions.
2018 Nazzaro, et al. (37) 140 HS US NM There is a relevant disagreement between clinical and US 
scores. US might discover non-clinically evident HS lesions, 
notably fistulae.
2018 Kanni, et al.(45) 20 HS US Linear 7–12-MHz US observations could be used to assess the efficacy of MABp1 
therapy in HS.
2019 Lacarrubba, et al. (35) 434 HS US 14–20 MHz The use of clinical grading only to assess HS severity may 
underestimate the real disease severity.
2019 Lyons, et al. (42) 1 HS US 8–18 MHz Pre-operative US can aid in evaluation of HS.
2019 Martorell, et al. (15) 143 HS US Linear upper range up to 18 
MHz
US can modify the clinical staging and therapeutic management 
in HS by detecting subclinical disease.
2019 Martorell, et al. (38) 117 HS US 18 MHz The US evaluation seems to play an important role to define the 
fistular patterns.
2019 Napolitano, et al. (7) 124 HS US NM US seems to have good agreement with clinical assessment of 
HS.
2019 Nazzaro, et al. (32) 24 Hs US (+CD) NM The study shows the correlation between vascularization of HS 
lesions assessed with CD and local pain.
2019 Nazzaro, et al. (46) 180 HS US 18–5 MHz US in HS might highlight the rational for permanent hair laser 
removal.
2019 Oranges, et al. (56) 50 HS US 48 MHz; 70 MHz UHFUS provides a better understanding of HS. Patients can be 
monitored more effectively, thereby preventing the most severe 
changes.
2019 Wortsman, et al. (18) 139 HS US Linear 15 MHz; linear 18 MHz; 
linear 70 MHz
US can detect early signs of HS that are linked to severity and 
2 types of fragmentation of the keratin, which could support the 
generation and perpetuation of the fluid collections and tunnels.
2019 Zussino, et al. (33) 3 Hs US (+ CD) NM The combination of US and CD seems to be a reliable instrument 
for differentiating between steatocystoma multiplex and HS 
lesions, particularly distinguishing HS pseudocystic nodules from 
true cysts of steatocystoma multiplex
2019 Caposiena Caro, et al. (44) 60 Hs US NM US observations could be used to assess the efficacy of 
clindamycin versus clindamycin plus rifampicin in HS treatment.
2020 Álvarez, et al. (57) 53 HS US NM US observations could be used to assess the efficacy of 
intralesional triamcinolone for fistulous tracts in HS.
2020 Cuenca-Barrales, et al. 
(41)
40 HS US Linear 7–15 MHz Preoperative ultrasonography improves surgical margin 
delimitation and can lower recurrence rates.
2020 Nazzaro, et al. (58) 1 HS IT and CD NM Role of infrared thermography in combination with CD seems 
to be a reliable tool for detecting the intensity of inflammation 
in HS.
AUS: anal ultrasonography; CD: colour Doppler; HS: suppurativa; HC: healthy control; IT: infrared thermography; NM: not mentioned; PC: pilonidal cysts; PD: power 
Doppler; TPUS: transperineal ultrasonography; UHFUS: ultra-high frequency ultrasound; US: ultrasound; VSD: various skin diseases; 3D: three-dimensional.
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the advances made over time (Tables II and III). Finally, 
the main emerging topics regarding the application of 
MRI and ultrasound in HS were discussed in more detail.
RESULTS 
A total of 441 articles were identified. Screening of the 
abstracts were results in exclusion of 391 articles. After 
full-text evaluation of the remaining 50 articles, a final 
total of 39 articles were included in this study (Fig. 3, 
Tables II and III).
Ultrasound imaging
Ultrasound is a non-invasive real-time method based on 
the propagation and return of sound waves in different 
tissues (6). Ultrasound could be of use in dermatology, 
by enabling physicians to visualize skin tissue and cu-
taneous lesions, according to their echogenicity (6, 11). 
Ultrasound imaging has been utilized for over 20 years 
in assessment of HS lesions (9, 12). During this time, 
ultrasound imaging of HS has advanced HS diagnosis, 
management and follow-up (6, 9, 12–17). The most com-
monly used ultrasound equipment for evaluating HS has 
a maximum frequency range of 15–22 MHz (18).
Ultrasound to determine the pathogenesis and clinical 
signs of hidradenitis suppurativa
US can reliably and non-invasively support better under-
standing the pathogenesis and diagnosis of HS, through 
real-time assessment of the characteristics, extension, 
and relationship of HS lesions with the surrounding 
tissues (19, 20). The anatomical information obtained 
with US supports our histological understanding of the 
evolution of HS (16).
The exact pathogenetic mechanism of HS remains un-
clear (3, 21). The primary event in disease development 
is thought to be follicular occlusion, based on histopat-
hological observations in very early lesions (3, 22, 23). 
Follicular occlusion is probably caused by infundibular 
keratosis and hyperplasia of the follicular epithelium, 
which results in accumulation of cellular debris and 
formation of cysts (3, 22, 24–26). Eventually, the hair 
follicle ruptures, followed by introduction of follicular 
contents to the surrounding dermis, which induces signi-
ficant expression of inflammatory mediators and recruit-
ment of inflammatory cells (3, 22, 24–26). Similar to the 
histological findings, the observed primary widening of 
hair follicles (probably due to the presence of follicular 
and perifollicular inflammation, and the increased size 
of the hair shafts, may be secondary to dysregulation of 
the production of keratin) seen on ultrasound, followed 
by dermal thickening and/or diffuse alteration of der-
mal echogenicity pattern (which reflects the underlying 
painful inflammatory process), formation of pseudo-
cysts in dermis (round or oval-shaped hypoechoic or 
anechoic nodular structures), fluid collection (anechoic 
or hypoechoic fluid deposits in the dermis or hypoder-
mis connected to the base of widened hair follicles), 
and fistulous tracts (anechoic or hypoechoic band-like 
structures across skin layers in the dermis or hypodermis 
connected to the base of widened hair follicles) (3, 8, 9, 
11, 12, 14, 16–20, 27–30). In addition, HS is an inflam-
matory disease, and yet palpable lymph nodes are rarely 
found clinically. However, ultrasound could be used to 
identify and measure regional lymph nodes in patients 
with HS, especially late-stage HS (31).
Doppler sonography
The combination of ultrasound and colour Doppler could 
provide additional information about HS lesions, such as 
vasculature components and inflammation, which might 
be correlated with local pain (6, 32). Furthermore, colour 
Doppler sonography might help to provide significant 
anatomical evidence and differentiate among steatocys-
toma multiplex, pilonidal cysts and HS lesions (33, 34). 
Grading and assessment of severity using ultrasound
The accurate evaluation of disease severity is an im-
portant and challenging task in HS (30). Clinical scoring 
based on physical findings is easy, but provides insuf-
ficient detail on the severity of HS (8). Ultrasound might 
add important findings in diagnosis and severity assess-
Table III. Summary of selected studies that showed application of magnetic resonance imaging (MRI) in hidradenitis suppurativa (HS)
Year Study
Patients
n
Selected radiologic 
method Scanner Comments
2005 Kelly, et al. (29) 1 HS MRI On a 1.5-T 
scanner
MRI shows important features of HS.
2014 Griffin, et al. (50) 18 HS MRI On a 1.5-T 
scanner
MRI may help define the extent of anogenital disease and assess response to 
treatment.
2014 Poh, et al. (5) 1 HS MRI NM MRI shows important features and complications of HS.
2015 Takiyama, et al. 
(49)
2 HS MRI NM Perianal HS with complicated anal fistulae can be diagnosed using MRI and 
treated safely.
2015 Virgilio, et al. 
(52)
1 HS MRI NM MRI can be used in the diagnosis and post-treatment evaluation of anogenital HS.
2017 Monnier, et al. 
(51)
23 HS; 46 CD MRI On a 1.5-T 
scanner
MRI features can help in differentiation of HS and CD.
2018 Derruau, et al. 
(53)
1 HS MRI On a 1.5-T 
scanner
Combining MRI and IT could help to distinguish healthy tissues and inflammatory 
sites during excision.
CD: Crohn’s disease; IT: infrared thermography; NM: not mentioned; T: Tesla.
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ment of HS (28). As a result, Wortsman et al. recommen-
ded a sonographic scoring system for HS (SOS-HS) to 
define disease severity. SOS-HS combined the results of 
parameters included in Hurley’s clinical staging with the 
relevant sonographic findings, i.e. number and distribu-
tion of fluid collections, fistulous tracts, pseudocystic 
nodules, widening of the hair follicles and changes in 
dermal thickness/echogenicity (8, 27). More recently, 
the 5 main lesions detectable by US have been validated: 
pseudocyst, fistulous tract, fluid collection, connected 
fistulous tracts, and hair tracts (13, 35). Using this score, 
recent studies have demonstrated a relevant disagreement 
between clinical and ultrasonography scores, due to the 
greater sensitivity of ultrasonography (7, 15, 30, 36, 37). 
Physical examination alone significantly underestimates 
the severity of HS and ultrasound-discovered subclinical 
HS lesions, notably fistulous tracts, which reflect a more 
aggressive disease (7, 15, 17, 30, 37–40).
Pre-operative planning using ultrasound
Surgical removal (or possibly laser therapy) can be 
used to remove lesional tissue with long-term inflam-
matory damage (3, 12, 17, 41). The size of the excision 
is important to improve clinical outcome and reduce the 
recurrence rate (12, 41). Current preoperative assessment 
of the necessary excision size is based mainly on clinical 
evaluation by the dermatologist and/or surgeon (12). 
However, a more exact preoperative assessment of the 
lesions and involved area of the skin could minimize the 
size of the excision, morbidities and recurrence rate (12). 
Clinical scoring of HS may underestimate the true extent 
of the disease, since visual examination and palpation 
pose difficulties in determining the presence of deeper 
lesions (42). Ultrasound can help to identify the location, 
size, and shape of the affected area and exclude other pos-
sible diagnosis (9, 12, 42, 43). Cuenca-Barrales et al. (41) 
showed recently that the use of pre-operative ultrasound 
planning in surgical management of HS improves surgical 
margin delimitation and reduces recurrence rates at 24 
weeks. This highlights the importance of a pre-operative 
evaluation to precisely identify excision targets and ela-
borate personalized surgical management of patients with 
HS to minimize the risk of recurrence (38, 42).
Use of ultrasound in planning and monitoring therapy 
Notable associations between morphological changes 
identified using ultrasound and patient assessments of 
flare activity and pain suggest that these parameters 
might be strong indicators of the degree of inflammation 
in HS (30). Thus, ultrasound might also be also useful in 
treatment response monitoring and follow-up, by non-
invasively observing and measuring the number and size 
of lesions, reduction/disappearance of fluid collections, 
and fistulous tracts or a decrease/lack of Doppler activity 
(8, 15, 35, 40, 44). Clinical studies have used ultrasound 
to monitor the efficacy of systemic and local therapies 
as intralesional triamcinolone, clindamycin plus rifam-
picin and MABp1 (a human monoclonal antibody that 
neutralizes IL-1a) (41, 44, 45). Since a high prevalence 
of retained hair tract, detected by ultrasound confirms 
the pathogenic role of hair follicle as a foreign body that 
stimulates chronic inflammation in HS, permanent hair 
removal might be suggested to all patients with mild-to-
moderate HS (8, 14, 46).
Limitations of ultrasound in hidradenitis suppurativa
Clear delineation between HS lesions, acne, folliculitis or 
cutaneous nodules using ultrasound findings may not be 
easy (27, 30, 42, 43, 47). In addition, ultrasound may not 
always be the best method for distinguishing HS fistulas 
from rectal fistulas or abscesses (27, 30, 42, 43, 47). In 
addition, ultrasound has limited ability to detect very 
small and/or very deep HS lesions (size/depth depends 
on sample frequency), which may impact on initial detec-
tion (8, 27, 30, 42, 43, 47). Furthermore, the correct use 
of ultrasound in HS, obtaining high-quality images and 
standardizing reporting requires specific training and a 
longer time than simple clinical examination (35, 42).
Magnetic resonance imaging
MRI uses the magnetic properties of the body, specifi-
cally hydrogen atoms present in water and fat, to produce 
an image (9, 48). MRI has been used in the diagnosis and 
treatment of severe and complex HS lesions for over a 
decade (9, 29, 48). As a result of increased inflamma-
tion, HS changes the water content of the tissue (9, 49). 
Such areas appear to consist of subcutaneous networks 
of sinus tracts, which are visible on MRI due to the high 
contrast resolution (9, 49).
Magnetic resonance imaging in determining pathogenesis 
of hidradenitis suppurativa and in clinical use 
The MRI findings of HS could be relatively non-specific, 
including marked thickening of the skin, induration of the 
subcutaneous tissues, and formation of multiple subcu-
taneous abscesses (5, 29). In the presence of anogenital 
involvement, MRI could help define the extent of HS 
and its associated complications, and may help exclude 
other differential possibilities, such as Crohn’s disease 
(50, 51). Furthermore, MRI also provides important 
additional information by a remarkable visualization 
of local enlarged lymph nodes, abscesses, and sinus 
tracts involving the rectum or other pelvic organs (5, 29, 
49–52). In addition, this non-invasive method may deter-
mine whether medical therapy needs to be escalated or 
whether surgical intervention is required (50). If surgery 
is indicated, MRI might also be used for preoperative 
assessment to avoid post-surgical recurrence or compli-
cations (42, 49, 50, 53).
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High-resolution magnetic resonance imaging using 
surface coils
Surface coils are used in MRI to better receive the radio-
frequency signal, as they are more sensitive to signals 
close to the coil, thus detecting signals from organs of 
interest more efficiently (54). There is a wide range of 
MRI coil types, which have good signal-to-noise ratio 
for the tissue adjacent to the coil (54). Therefore, detec-
tion of magnetic resonance signals with surface coils 
provides increased signal-to-noise ratio for superficial 
structures, such as skin layers and their abnormalities (54, 
55). Different geometries of surface coils can be used for 
different regions. Coils that are flat or curved to fit body 
contours are useful for general imaging, with a range of 
coil sizes for structures of different sizes or depths (55).
Conclusion
Ultrasound and MRI are the main modalities of imaging 
commonly used in patients with HS (9). Ultrasound is a 
well-stablished, non-invasive imaging method that has 
improved the assessment of disease severity, treatment 
selection, preoperative planning, evaluation of therapy ef-
fectiveness and monitoring of HS complications through 
real-time assessment of the features, extension and 
relationship of HS lesions with the surrounding tissues 
(5, 9, 19, 20, 35).
In addition, ultra-high-frequency ultrasound can help 
improve our understanding of the evolution of HS from 
early to advanced stages and thus contribute to under-
standing of the pathogenesis and early diagnosis of HS 
(18, 56). Using MRI localization, the depth, size and 
number of the HS lesions, especially fistulas and sinus 
tracts, could be assessed more precisely compared with 
ultrasound, due to the high-contrast resolution. Further-
more, disease activity parameters, such as expansion, 
local oedema, tissue inflammation and scar formation 
might be evaluated better using MRI, compared with 
ultrasound. As MRI is not user-dependent, it is a more 
practical technique to follow patients and analyse their 
therapy responses. In addition, MRI is a recommend 
radiological modality for specific localizations, such 
as the anogenital area. As a result, MRI can be used to 
evaluate the distribution of HS lesions, perform correct 
staging, select the proper treatment and for pre-surgical 
planning. MRI findings include thickening of the skin, 
induration of the subcutaneous tissue and multiple ab-
scesses. However, MRI should be reserved for complex 
and challenging cases, especially in the presence of 
anogenital involvement.
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